書誌事項
- タイトル別名
-
- Understanding of molecular pathogenesis of Alzheimer's disease. Implications for drug development.
- アルツハイマービョウ ノ ブンシ ビョウタイ ト チリョウヤク カイハツ エ ノ シシン
この論文をさがす
抄録
Recent advances in the knowledge about Alzheimer pathogenesis indicate several tactics for the development of drugs to treat Alzheimer's disease. Firstly, the function of presenilin, the causative gene for most familial Alzheimer's disease, has been demonstrated to be the protease in the Notch signaling system. Pre-senilin cleaves the transmembrane domain of the C-terminal fragment of the Notch-1 molecule, which is generated by proteolysis by furin-like proteases. APP is also cleaved by presenilin at the γcut site, implying that presenilin is γ-secretase itself or at least closely functioning with γ-secretase. A recent paper has demonstrated that immunization of APP transgenic mouse with amyloid β42 may decrease and prevent amyloid deposition in brain tissue. This unique and novel approach may open the new tactics for developing anti-dementia drugs. Another important finding comes from the identification of the function of prolyl isomerase. It is demonstrated that pin 1, intra-nuclear prolyl isomerase, can restore the microtubule binding capacity of phosphorylated tau, which clearly shows a solid strategy for developing drugs for preventing neuronal degeneration.
収録刊行物
-
- 日本薬理学雑誌
-
日本薬理学雑誌 115 (2), 79-88, 2000
公益社団法人 日本薬理学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390282679250039040
-
- NII論文ID
- 10005705525
-
- NII書誌ID
- AN00198335
-
- COI
- 1:CAS:528:DC%2BD3cXpsVChtQ%3D%3D
-
- ISSN
- 13478397
- 00155691
-
- NDL書誌ID
- 4974745
-
- PubMed
- 10876794
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可